Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C (compound name: OLX72021), an...
Search results for "Phase 1b"
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the Phase 1b clinical trial for its...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise
Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
ABL Bio Publishes Review Paper on Dual Antibodies in International Journal
ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody...
1